|
1
|
Fidler IJ: The pathogenesis of cancer
metastasis: The ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization of squamous cell lung
cancers. Nature. 489:519–525. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cancer Genome Atlas Research Network, .
Comprehensive molecular profiling of lung adenocarcinoma. Nature.
511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Weinstein IB: Addiction to oncogenes - the
Achilles heal of cancer. Science. 297:63–64. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L:
International Association for the Study of Lung Cancer
International Staging Committee; Participating Institutions: The
IASLC Lung Cancer Staging Project: Proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM classification of malignant tumors. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sequist LV, Waltman BA, Dias-Santagata D,
Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger
S, Cosper AK, et al: Genotypic and histological evolution of lung
cancers acquiring resistance to EGFR inhibitors. Sci Transl Med.
3:75ra26. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bloom G, Yang IV, Boulware D, Kwong KY,
Coppola D, Eschrich S, Quackenbush J and Yeatman TJ:
Multi-platform, multi-site, microarray-based human tumor
classification. Am J Pathol. 164:9–16. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Varadhachary GR and Raber MN: Cancer of
unknown primary site. N Engl J Med. 371:757–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Riely GJ, Politi KA, Miller VA and Pao W:
Update on epidermal growth factor receptor mutations in non-small
cell lung cancer. Clin Cancer Res. 12:7232–7241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ruffini E, Rena O, Oliaro A, Filosso PL,
Bongiovanni M, Arslanian A, Papalia E and Maggi G: Lung tumors with
mixed histologic pattern. Clinico-pathologic characteristics and
prognostic significance. Eur J Cardiothorac Surg. 22:701–707. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li DH, Wang C, Chen HJ, Huang H and Ding
ZY: Clinical characteristics of the mixed form of neuroendocrine
tumor in the lung: A retrospective study in 2501 lung cancer cases.
Thorac Cancer. 6:25–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
de Bruin EC, McGranahan N, Mitter R, Salm
M, Wedge DC, Yates L, Jamal-Hanjani M, Shafi S, Murugaesu N, Rowan
AJ, et al: Spatial and temporal diversity in genomic instability
processes defines lung cancer evolution. Science. 346:251–256.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Glass R, Hukku SR, Gershenhorn B, Alzate J
and Tan B: Metastasis of lung adenosquamous carcinoma to
meningioma: Case report with literature review. Int J Clin Exp
Pathol. 6:2625–2630. 2013.PubMed/NCBI
|
|
17
|
Shelton DA, Rana DN, Holbrook M, Taylor P
and Bailey S: Adenosquamous carcinoma of the lung diagnosed by
cytology? A diagnostic dilemma. Diagn Cytopathol. 40:830–833. 2012.
View Article : Google Scholar : PubMed/NCBI
|
